Found: 44
Select item for more details and to access through your institution.
Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement?
- Published in:
- 2010
- By:
- Publication type:
- journal article
Economic Burden of Opioid-Induced Constipation Among Long-Term Opioid Users with Noncancer Pain.
- Published in:
- American Health & Drug Benefits, 2015, v. 8, n. 2, p. 93
- By:
- Publication type:
- Article
Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1292, doi. 10.1111/dom.14979
- By:
- Publication type:
- Article
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1861, doi. 10.1111/dom.14775
- By:
- Publication type:
- Article
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2242, doi. 10.1111/dom.14465
- By:
- Publication type:
- Article
Patients' preferences for once‐daily oral versus once‐weekly injectable diabetes medications: The REVISE study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 508, doi. 10.1111/dom.14244
- By:
- Publication type:
- Article
Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatide BCise: 6‐month follow‐up from US real‐world data.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 106, doi. 10.1111/dom.14195
- By:
- Publication type:
- Article
Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1299, doi. 10.1111/dom.13649
- By:
- Publication type:
- Article
Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month follow‐up in a real‐world setting in the United States.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 920, doi. 10.1111/dom.13603
- By:
- Publication type:
- Article
Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 953, doi. 10.1111/dom.12902
- By:
- Publication type:
- Article
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 6, p. 815, doi. 10.1093/neuonc/nou028
- By:
- Publication type:
- Article
Cumulative cost pattern comparison of prostate cancer treatments.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 3, p. 518, doi. 10.1002/cncr.22433
- By:
- Publication type:
- Article
Nanomedicine.
- Published in:
- Internet Journal of Medical Update, 2011, v. 6, n. 1, p. 1
- By:
- Publication type:
- Article
Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01386-4
- By:
- Publication type:
- Article
Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165435
- By:
- Publication type:
- Article
Variation in Care for Patients with Irritable Bowel Syndrome in the United States.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0154258
- By:
- Publication type:
- Article
Changes in Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitors after an FDA Safety Communication.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0145504
- By:
- Publication type:
- Article
Seasonal patterns of abdominal pain consultations among adults and children.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
DEVELOPING PROFILES OF POSTMENOPAUSAL WOMEN BEING PRESCRIBED ESTROGEN THERAPY TO PREVENT OSTEOPOROSIS.
- Published in:
- Journal of Community Health, 2002, v. 27, n. 5, p. 335, doi. 10.1023/A:1019836610275
- By:
- Publication type:
- Article
Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2045, doi. 10.1007/s13300-023-01470-w
- By:
- Publication type:
- Article
Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 11/12, p. 1921, doi. 10.1007/s13300-022-01320-1
- By:
- Publication type:
- Article
Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1437, doi. 10.1007/s13300-020-00839-5
- By:
- Publication type:
- Article
Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1513, doi. 10.1007/s13300-020-00838-6
- By:
- Publication type:
- Article
Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants.
- Published in:
- Quality of Life Research, 2010, v. 19, n. 4, p. 551, doi. 10.1007/s11136-010-9620-x
- By:
- Publication type:
- Article
Long-term Efficacy of Vedolizumab for Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 4, p. 400, doi. 10.1093/ecco-jcc/jjw177
- By:
- Publication type:
- Article
Long-term Efficacy of Vedolizumab for Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 4, p. 412, doi. 10.1093/ecco-jcc/jjw176
- By:
- Publication type:
- Article
Gastroenterologists' Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale Survey.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Impact of Not on Tobacco on Teen Smoking Cessation: End-of-Program Evaluation Results, 1998 to 2003.
- Published in:
- Journal of Adolescent Research, 2005, v. 20, n. 6, p. 640, doi. 10.1177/0743558405274891
- By:
- Publication type:
- Article
Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 19, p. 1458, doi. 10.1093/jnci/djs357
- By:
- Publication type:
- Article
Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy.
- Published in:
- ClinicoEconomics & Outcomes Research, 2013, v. 5, p. 161, doi. 10.2147/CEOR.S41189
- By:
- Publication type:
- Article
The Effect of Dexlansoprazole MR on Nocturnal Heartburn and GERD-Related Sleep Disturbances in Patients With Symptomatic GERD.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 3, p. 421, doi. 10.1038/ajg.2010.458
- By:
- Publication type:
- Article
982-P: Use of Antihyperglycemic Agents (AHA) with Cardioprotective Benefit in Older Patients with T2D and CVD or CV Risk Factors.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-982-P
- By:
- Publication type:
- Article
851-P: Are We There Yet? Increasing Use of Cardioprotective Antihyperglycemic Agents in Patients with T2D and CVD or CV Risk in the U.S.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-851-P
- By:
- Publication type:
- Article
654-P: Greater Adherence and Persistence with Dulaglutide Compared with Semaglutide at 6- and 12-Months Follow-up in U.S. Real-World Data.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-654-P
- By:
- Publication type:
- Article
649-P: Impact of Early Initiation of Dulaglutide on A1C in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-649-P
- By:
- Publication type:
- Article
938-P: The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-938-P
- By:
- Publication type:
- Article
929-P: Dulaglutide Shows Sustained A1C Reduction: Two-Year U.S. Real-World Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-929-P
- By:
- Publication type:
- Article
928-P: Dulaglutide Has Higher Adherence and Persistence than Semaglutide and Exenatide QW: 6-Month Follow-Up from U.S. Real-World Data.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-928-P
- By:
- Publication type:
- Article
924-P: Exploring Potential Mediators of the Cardiovascular Benefit of Dulaglutide in REWIND.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-924-P
- By:
- Publication type:
- Article
1259-P: Adherence and Persistence for Dulaglutide (DU) vs. Basal Insulin (BI) in Injection-Naïve Patients with Type 2 Diabetes (T2D): The DISPELTM Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1259-P
- By:
- Publication type:
- Article
992-P: Dulaglutide (DU) Has Better Glycemic Effectiveness vs. Basal Insulin (BI) in Injection-Naïve Patients with Type 2 Diabetes (T2D): The DISPELTM Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-992-P
- By:
- Publication type:
- Article
Smoking status and health-related quality of life: as findings from the 2001 Behavioral Risk Factor Surveillance System data.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Smoking Status and Health-related Quality of Life: Findings From the 2001 Behavioral Risk Factor Surveillance System Data.
- Published in:
- American Journal of Health Promotion, 2006, v. 20, n. 4, p. 251, doi. 10.4278/0890-1171-20.4.251
- By:
- Publication type:
- Article